Downstream of Mutant KRAS, the Transcription Regulator YAP Is Essential for Neoplastic Progression to Pancreatic Ductal Adenocarcinoma

Bioconductor: open software development for computational biology and bioinformatics

Gentleman, R., Carey, V., Bates, D., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome Biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 13,133 · see citing works

Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments

Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829 · see citing works

Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control

Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092 · see citing works

Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations

Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002) · Science · doi:10.1126/science.1067100 · Cited by 2,761 · see citing works

Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice

Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609 · see citing works

TEAD mediates YAP-dependent gene induction and growth control

Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M., et al. (2008) · Genes & Development · doi:10.1101/gad.1664408 · Cited by 2,498 · see citing works

Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse

Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471 · see citing works

Elucidation of a universal size-control mechanism in Drosophila and mammals

Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., Anders, R. A., Maitra, A., & Pan, D. (2007) · Cell · doi:10.1016/j.cell.2007.07.019 · Cited by 2,370 · see citing works

The Hippo Signaling Pathway in Development and Cancer

Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.011 · Cited by 2,274 · see citing works

The Hippo Signaling Pathway Coordinately Regulates Cell Proliferation and Apoptosis by Inactivating Yorkie, the Drosophila Homolog of YAP

Huang, J., Wu, S., Barrera, J. A., Matthews, K. A., & Pan, D. (2005) · Cell · doi:10.1016/j.cell.2005.06.007 · Cited by 1,870 · see citing works

Formation and function of the myofibroblast during tissue repair

Hinz, B. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700613 · Cited by 1,658 · see citing works

Genetic and pharmacological disruption of the TEAD–YAP complex suppresses the oncogenic activity of YAP

Liu-Chittenden, Y., Huang, B., Shim, J. S., Chen, Q., Lee, S.-J., Anders, R. A., Liu, J. O., & Pan, D. (2012) · Genes & Development · doi:10.1101/gad.192856.112 · Cited by 1,452 · see citing works

A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF ^β-TRCP

Zhao, B., Li, L., Tumaneng, K., Wang, C.-Y., & Guan, K.-L. (2010) · Genes & Development · doi:10.1101/gad.1843810 · Cited by 1,418 · see citing works

The Pancreas Cancer Microenvironment

Feig, C., Gopinathan, A., Neesse, A., Chan, D. S., Cook, N., & Tuveson, D. A. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3114 · Cited by 1,316 · see citing works

Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome

Olive, K. P., Tuveson, D. A., Ruhe, Z. C., Yin, B., Willis, N. A., Bronson, R. T., Crowley, D., & Jacks, T. (2004) · Cell · doi:10.1016/j.cell.2004.11.004 · Cited by 1,308 · see citing works

YAP1 increases organ size and expands undifferentiated progenitor cells

Camargo, F. D., Gokhale, S., Johnnidis, J. B., Fu, D., Bell, G. W., Jaenisch, R., & Brummelkamp, T. R. (2007) · Current Biology · doi:10.1016/j.cub.2007.10.039 · Cited by 1,252 · see citing works

Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice

Guerra, C., Schuhmacher, A. J., Cañamero, M., Grippo, P. J., Verdaguer, L., Pérez-Gallego, L., Dubus, P., Sandgren, E. P., & Barbacid, M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.01.012 · Cited by 1,224 · see citing works

Pancreatic Carcinoma

Warshaw, A. L., & Castillo, C. F. F.-D. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202133260706 · Cited by 1,200 · see citing works

Somatic activation of the K-ras oncogene causes early onset lung cancer in mice

Johnson, L., Mercer, K., Greenbaum, D., Bronson, R. T., Crowley, D., Tuveson, D. A., & Jacks, T. (2001) · Nature · doi:10.1038/35074129 · Cited by 1,179 · see citing works

hippo Encodes a Ste-20 Family Protein Kinase that Restricts Cell Proliferation and Promotes Apoptosis in Conjunction with salvador and warts

Wu, S., Huang, J., Dong, J., & Pan, D. (2003) · Cell · doi:10.1016/s0092-8674(03)00549-x · Cited by 1,101 · see citing works

Activated Kras and <i>Ink4a/Arf</i> deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma

Aguirre, A. J., Bardeesy, N., Sinha, M., Lopez, L., Tuveson, D. A., Horner, J., Redston, M. S., & DePinho, R. A. (2003) · Genes &amp; Development · doi:10.1101/gad.1158703 · Cited by 1,033 · see citing works

The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors

Kawaguchi, Y., Cooper, B., Gannon, M., Ray, M., MacDonald, R. J., & Wright, C. V. E. (2002) · Nature Genetics · doi:10.1038/ng959 · Cited by 1,007 · see citing works

Dynamics of the immune reaction to pancreatic cancer from inception to invasion

Clark, C. E., Hingorani, S. R., Mick, R., Combs, C., Tuveson, D. A., & Vonderheide, R. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0175 · Cited by 990 · see citing works

The Drosophila Mst Ortholog, hippo, Restricts Growth and Cell Proliferation and Promotes Apoptosis

Harvey, K. F., Pfleger, C. M., & Hariharan, I. K. (2003) · Cell · doi:10.1016/s0092-8674(03)00557-9 · Cited by 983 · see citing works

The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation.

Justice, R. W., Zilian, O., Woods, D. F., Noll, M., & Bryant, P. J. (1995) · Genes &amp; Development · doi:10.1101/gad.9.5.534 · Cited by 977 · see citing works

Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 Oncogene

Zhou, D., Conrad, C. H., Xia, F., Park, J.-S., Payer, B., Yin, Y., Lauwers, G. Y., Thasler, W. E., Lee, J. T., Avruch, J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.09.026 · Cited by 916 · see citing works

Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer

Lesina, M., Kurkowski, M. U., Ludes, K., Rose-John, S., Treiber, M., Klöppel, G., Yoshimura, A., Reindl, W., Sipos, B., Akira, S., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.009 · Cited by 862 · see citing works

salvador Promotes Both Cell Cycle Exit and Apoptosis in Drosophila and Is Mutated in Human Cancer Cell Lines

Tapon, N., Harvey, K. F., Bell, D. W., Wahrer, D. C. R., Schiripo, T. A., Haber, D. A., & Hariharan, I. K. (2002) · Cell · doi:10.1016/s0092-8674(02)00824-3 · Cited by 858 · see citing works

The Merlin/NF2 Tumor Suppressor Functions through the YAP Oncoprotein to Regulate Tissue Homeostasis in Mammals

Zhang, N., Bai, H., David, K. K., Dong, J., Zheng, Y., Cai, J., Giovannini, M., Liu, P., Anders, R. A., & Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.06.015 · Cited by 804 · see citing works

Endogenous oncogenic K-rasG12D stimulates proliferation and widespread neoplastic and developmental defects

Tuveson, D. A., Shaw, A. T., Willis, N. A., Silver, D. P., Jackson, E. L., Chang, S., Mercer, K. L., Grochow, R., Hock, H., Crowley, D., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00085-6 · Cited by 798 · see citing works

Tumor Suppressor LATS1 Is a Negative Regulator of Oncogene YAP

Hao, Y., Chun, A., Cheung, K. J., Rashidi, B., & Yang, X. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m709037200 · Cited by 780 · see citing works

TAZ: a novel transcriptional co‐activator regulated by interactions with 14‐3‐3 and PDZ domain proteins

Kanai, F., Marignani, P. A., Sarbassova, D., Yagi, R., Hall, R. A., Donowitz, M., Hisaminato, A., Fujiwara, T., Ito, Y., Cantley, L. C., et al. (2000) · The EMBO Journal · doi:10.1093/emboj/19.24.6778 · Cited by 758 · see citing works

Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway

Udan, R. S., Kango-Singh, M., Nolo, R., Tao, C., & Halder, G. (2003) · Nature Cell Biology · doi:10.1038/ncb1050 · Cited by 747 · see citing works

Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver

Lu, L., Li, Y., Kim, S. M., Bossuyt, W., Liu, P., Qiu, Q., Wang, Y., Halder, G. A., Finegold, M. J., Lee, J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911427107 · Cited by 721 · see citing works

TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm

Vassilev, A., Kaneko, K. J., Shu, H., Zhao, Y., & DePamphilis, M. L. (2001) · Genes &amp; Development · doi:10.1101/gad.888601 · Cited by 719 · see citing works

FKBP51 Affects Cancer Cell Response to Chemotherapy by Negatively Regulating Akt

Pei, H., Li, L., Fridley, B. L., Jenkins, G. D., Kalari, K. R., Lingle, W., Petersen, G., Lou, Z., & Wang, L. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.07.016 · Cited by 709 · see citing works

Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma

Kopp, J. L., von Figura, G., Mayes, E., Liu, F.-F., Dubois, C. L., Morris, J. P., Pan, F. C., Akiyama, H., Wright, C. V. E., Jensen, K., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.10.025 · Cited by 697 · see citing works

Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling

Jones, S. A., Scheller, J., & Rose‐John, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57158 · Cited by 683 · see citing works

<i>Smad4</i> is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer

Bardeesy, N., Cheng, K.-H., Berger, J. H., Chu, G. C., Pahler, J., Olson, P., Hezel, A. F., Horner, J., Lauwers, G. Y., Hanahan, D., et al. (2006) · Genes &amp; Development · doi:10.1101/gad.1478706 · Cited by 674 · see citing works

The Salvador–Warts–Hippo pathway — an emerging tumour-suppressor network

Harvey, K., & Tapon, N. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2070 · Cited by 628 · see citing works

A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer

Jiao, S., Wang, H., Shi, Z., Dong, A., Zhang, W., Song, X., He, F., Wang, Y., Zhang, Z., Wang, W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.010 · Cited by 605 · see citing works

Control of Cell Proliferation and Apoptosis by Mob as Tumor Suppressor, Mats

Lai, Z.-C., Wei, X., Shimizu, T., Ramos, E., Rohrbaugh, M., Nikolaidis, N., Ho, L., & Li, Y. (2005) · Cell · doi:10.1016/j.cell.2004.12.036 · Cited by 570 · see citing works

A WW domain‐containing Yes‐associated protein (YAP) is a novel transcriptional co‐activator

Yagi, R., Chen, L. F., Shigesada, K., Murakami, Y., & Ito, Y. (1999) · The EMBO Journal · doi:10.1093/emboj/18.9.2551 · Cited by 553 · see citing works

Stat3 and MMP7 Contribute to Pancreatic Ductal Adenocarcinoma Initiation and Progression

Fukuda, A., Wang, S. C., Morris, J. P., Folias, A. E., Liou, A., Kim, G. E., Akira, S., Boucher, K., Firpo, M., Mulvihill, S., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.002 · Cited by 531 · see citing works

Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia.

Badea, L., Herlea, V., Dima, S., Dumitraşcu, T., & Popescu, I. (2008) · PubMed · Cited by 531 · see citing works

EGF Receptor is Required for KRAS-induced Pancreatic Tumorigenesis

Ardito, C. M., Grüner, B., Takeuchi, K. K., Lubeseder-Martellato, C., Teichmann, N., Mazur, P., DelGiorno, K. E., Carpenter, E. S., Halbrook, C., Hall, J. C., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.07.024 · Cited by 522 · see citing works

KrasG12D-Induced IKK2/β/NF-κB Activation by IL-1α and p62 Feedforward Loops Is Required for Development of Pancreatic Ductal Adenocarcinoma

Ling, J., Kang, Y., Zhao, R., Xia, Q., Lee, D.-F., Chang, Z., Li, J., Peng, B., Fleming, J. B., Wang, H., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.12.006 · Cited by 513 · see citing works

The Emerging Role of the Hippo Pathway in Cell Contact Inhibition, Organ Size Control, and Cancer Development in Mammals

Zeng, Q., & Hong, W. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.011 · Cited by 436 · see citing works

Taxol Resistance in Breast Cancer Cells Is Mediated by the Hippo Pathway Component TAZ and Its Downstream Transcriptional Targets<i>Cyr61</i>and<i>CTGF</i>

Lai, D., Ho, K. C., Hao, Y., & Yang, X. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2711 · Cited by 416 · see citing works

LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker

Chen, D., Sun, Y., Wei, Y., Zhang, P., Rezaeian, A. H., Teruya‐Feldstein, J., Gupta, S., Liang, H., Lin, H., Hung, M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2940 · Cited by 413 · see citing works

Structural insights into the YAP and TEAD complexPreprint

Li, Z., Zhao, B., Wang, P., Chen, F., Dong, Z., Yang, H., Guan, K., & Xu, Y. (2010) · Genes & Development · doi:10.1101/gad.1865810 · Cited by 406 · see citing works

Untitled work

(1994) · PubMed · Cited by 404 · see citing works

EGF Receptor Signaling Is Essential for K-Ras Oncogene-Driven Pancreatic Ductal Adenocarcinoma

Navas, C., Hernández-Porras, I., Schuhmacher, A. J., Sibilia, M., Guerra, C., & Barbacid, M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.001 · Cited by 391 · see citing works

Genetic progression in the pancreatic ducts

Hruban, R. H., Wilentz, R. E., & Kern, S. E. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65054-7 · Cited by 373 · see citing works

Selective requirement of PI3K/PDK1 signaling for Kras oncogene-driven pancreatic cell plasticity and cancer

Eser, S., Reiff, N., Messer, M., Seidler, B., Gottschalk, K., Dobler, M., Hieber, M., Arbeiter, A., Klein, S., Kong, B., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.01.023 · Cited by 360 · see citing works

Frequency of K-ras Mutations in Pancreatic Intraductal Neoplasias Associated with Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis: A Meta-Analysis

Löhr, M., Klöppel, G., Maisonneuve, P., Lowenfels, A. B., & Lüttges, J. (2005) · Neoplasia · doi:10.1593/neo.04445 · Cited by 343 · see citing works

Characterization of the Mammalian YAP (Yes-associated Protein) Gene and Its Role in Defining a Novel Protein Module, the WW Domain

Sudol, M., Bork, P., Einbond, A., Kastury, K., Druck, T., Negrini, M., Huebner, K., & Lehman, D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.24.14733 · Cited by 342 · see citing works

Overexpression of yes‐associated protein contributes to progression and poor prognosis of non‐small‐cell lung cancer

Wang, Y., Dong, Q., Zhang, Q., Li, Z., Wang, E., & Qiu, X. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01511.x · Cited by 341 · see citing works

Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1

Fan, R., Kim, N., & Gumbiner, B. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216462110 · Cited by 339 · see citing works

The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene

Zhang, X., George, J., Deb, S., Degoutin, J. L., Takano, E. A., Fox, S. B., Chenevix‐Trench, G., Bowtell, D. D. L., & Harvey, K. F. (2011) · Oncogene · doi:10.1038/onc.2011.8 · Cited by 308 · see citing works

c-Raf, but not B-Raf, is essential for development of K-Ras oncogene-driven non-small cell lung carcinoma

Blasco, R. B., Francoz, S., Santamaría, D., Cañamero, M., Dubus, P., Charron, J., Baccarini, M., & Barbacid, M. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.04.002 · Cited by 302 · see citing works

Regulation of the Hippo–YAP pathway by protease-activated receptors (PARs)Preprint

Mo, J., Yu, F., Gong, R., Brown, J. H., & Guan, K. (2012) · Genes & Development · doi:10.1101/gad.197582.112 · Cited by 282 · see citing works

Wnt/β-Catenin Signaling Regulates Yes-associated Protein (YAP) Gene Expression in Colorectal Carcinoma Cells

Raup‐Konsavage, W. M., Kyler, S. L., Rennoll, S. A., Jin, G., & Yochum, G. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.327767 · Cited by 277 · see citing works

Regulation of Hippo Signaling by EGFR-MAPK Signaling through Ajuba Family Proteins

Reddy, B. V. V. G., & Irvine, K. D. (2013) · Developmental Cell · doi:10.1016/j.devcel.2013.01.020 · Cited by 271 · see citing works

Hippo Pathway Effector Yap Is an Ovarian Cancer Oncogene

Hall, C. A., Wang, R., Miao, J., Oliva, E., Shen, X., Wheeler, T. M., Hilsenbeck, S. G., Oršulić, S., & Goode, S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1242 · Cited by 265 · see citing works

A Tight Junction-Associated Merlin-Angiomotin Complex Mediates Merlin's Regulation of Mitogenic Signaling and Tumor Suppressive Functions

Yi, C., Troutman, S. A., Fera, D., Stemmer-Rachamimov, A. O., Avila, J. L., Christian, N., Persson, N. L., Shimono, A., Speicher, D. W., Marmorstein, R., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.02.017 · Cited by 260 · see citing works

Yes-Associated Protein 1 Exhibits Oncogenic Property in Gastric Cancer and Its Nuclear Accumulation Associates with Poor Prognosis

Kang, W., TONG, J. H. M., Chan, A. W. H., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2467 · Cited by 260 · see citing works

Tumorigenic Potential of Extracellular Matrix Metalloproteinase Inducer

Zucker, S., Hymowitz, M., Rollo, E. E., Mann, R., Conner, C. E., Cao, J. P., Foda, H. D., Tompkins, D. C., & Toole, B. P. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64660-3 · Cited by 256 · see citing works

Crosstalk between the canonical NF-κB and Notch signaling pathways inhibits Pparγ expression and promotes pancreatic cancer progression in mice

Maniati, E., Bossard, M., Cook, N., Candido, J. B., Emami-Shahri, N., Nedospasov, S. A., Balkwill, F. R., Tuveson, D. A., & Hagemann, T. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45797 · Cited by 249 · see citing works

CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer

Neeße, A., Frese, K. K., Bapiro, T. E., Nakagawa, T., Sternlicht, M. D., Seeley, T. W., Pilarsky, C. P., Jodrell, D. I., Spong, S. M., & Tuveson, D. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300415110 · Cited by 248 · see citing works

YAP is a candidate oncogene for esophageal squamous cell carcinoma

Muramatsu, T., Imoto, I., Matsui, T., Kozaki, K., Haruki, S., Sudol, M., Shimada, Y., Tsuda, H., Kawano, T., & Inazawa, J. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq254 · Cited by 227 · see citing works

Notch2 is required for progression of pancreatic intraepithelial neoplasia and development of pancreatic ductal adenocarcinoma

Mazur, P. K., Einwächter, H., Lee, M., Sipos, B., Nakhai, H., Rad, R., Zimber‐Strobl, U., Strobl, L. J., Radtke, F., Klöppel, G., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002423107 · Cited by 219 · see citing works

Ras/Mitogen-Activated Protein Kinase Signaling Activates Ets-1 and Ets-2 by CBP/p300 Recruitment

Foulds, C. E., Nelson, M. L., Blaszczak, A. G., & Graves, B. J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10954-10964.2004 · Cited by 190 · see citing works

The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer

Groblewska, M., Siewko, M., Mroczko, B., et al. (2012) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.2012.0002 · Cited by 180 · see citing works

CXCL17 and ICAM2 Are Associated With a Potential Anti-Tumor Immune Response in Early Intraepithelial Stages of Human Pancreatic Carcinogenesis

Hiraoka, N., Yamazaki–Itoh, R., Ino, Y., Mizuguchi, Y., Yamada, T., Hirohashi, S., & Kanai, Y. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.10.009 · Cited by 175 · see citing works

What We Have Learned About Pancreatic Cancer From Mouse Models

Pérez-Mancera, P. A., Guerra, C. E., Barbacid, M., & Tuveson, D. A. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.03.002 · Cited by 173 · see citing works

Control of the Hippo Pathway by Set7-Dependent Methylation of Yap

Oudhoff, M. J., Freeman, S. A., Couzens, A. L., Antignano, F., Kuznetsova, E., Min, P. H., Northrop, J. P., Lehnertz, B., Baršytė-Lovejoy, D., Vedadi, M., et al. (2013) · Developmental Cell · doi:10.1016/j.devcel.2013.05.025 · Cited by 173 · see citing works

A cell-based assay to screen stimulators of the Hippo pathway reveals the inhibitory effect of dobutamine on the YAP-dependent gene transcription

Bao, Y., Nakagawa, K., Yang, Z. H., Ikeda, M., Withanage, K., Ishigami‐Yuasa, M., Okuno, Y., Hata, S., Nishina, H., & Hata, Y. (2011) · The Journal of Biochemistry · doi:10.1093/jb/mvr063 · Cited by 172 · see citing works

The p130 Isoform of Angiomotin Is Required for Yap-Mediated Hepatic Epithelial Cell Proliferation and Tumorigenesis

Yi, C., Shen, Z., Stemmer-Rachamimov, A. O., Dawany, N. B., Troutman, S. A., Showe, L. C., Liu, Q., Shimono, A., Sudol, M., Holmgren, L., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004060 · Cited by 168 · see citing works

Yes-Associated Protein 1 Is Widely Expressed in Human Brain Tumors and Promotes Glioblastoma Growth

Orr, B. A., Bai, H., Odia, Y., Jain, D., Anders, R. A., & Eberhart, C. G. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31821ff8d8 · Cited by 167 · see citing works

TRIB2 Acts Downstream of Wnt/TCF in Liver Cancer Cells to Regulate YAP and C/EBPα Function

Wang, J., Park, J., Wei, Y., Rajurkar, M., Cotton, J. L., Fan, Q., Lewis, B. C., Ji, H., & Mao, J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.05.013 · Cited by 160 · see citing works

Molecular Pathways: YAP and TAZ Take Center Stage in Organ Growth and Tumorigenesis

Piccolo, S., Cordenonsi, M., & Dupont, S. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3172 · Cited by 154 · see citing works

Hippo Signaling Regulates Differentiation and Maintenance in the Exocrine Pancreas

Gao, T., Zhou, D., Yang, C., Singh, T., Penzo‐Méndez, A., Maddipati, R., Tzatsos, A., Bardeesy, N. M., Avruch, J., & Stanger, B. Z. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.037 · Cited by 151 · see citing works

C-Raf Is Required for the Initiation of Lung Cancer by K-RasG12D

Karreth, F. A., Frese, K. K., DeNicola, G. M., Baccarini, M., & Tuveson, D. A. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-10-0044 · Cited by 149 · see citing works

Phosphorylation of the Carboxyl-Terminal Transactivation Domain of c-Fos by Extracellular Signal-Regulated Kinase Mediates the Transcriptional Activation of AP-1 and Cellular Transformation Induced by Platelet-Derived Growth Factor

Monje, P. V., Marinissen, M. J., & Gutkind, J. S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.19.7030-7043.2003 · Cited by 148 · see citing works

Connective Tissue Growth Factor–Specific Monoclonal Antibody Therapy Inhibits Pancreatic Tumor Growth and Metastasis

Dornhöfer, N., Spong, S. M., Bennewith, K. L., Salim, A., Klaus, S. J., Kambham, N., Wong, C., Kaper, F., Sutphin, P. D., Nacalumi, R., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0081 · Cited by 144 · see citing works

The Role of Tumor Cell–Derived Connective Tissue Growth Factor (CTGF/CCN2) in Pancreatic Tumor Growth

Bennewith, K. L., Huang, X., Ham, C. M., Graves, E. E., Erler, J. T., Kambham, N., Feazell, J., Yang, G. P., Koong, A. C., & Giaccia, A. J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-0987 · Cited by 142 · see citing works

Early Requirement of Rac1 in a Mouse Model of Pancreatic Cancer

Heid, I., Lubeseder–Martellato, C., Sipos, B., Mazur, P. K., Lesina, M., Schmid, R. M., & Siveke, J. T. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.043 · Cited by 139 · see citing works

Hippo Signaling Regulates Pancreas Development through Inactivation of Yap

George, N. M., Day, C. E., Boerner, B. P., Johnson, R. L., & Sarvetnick, N. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.01034-12 · Cited by 135 · see citing works

JNK phosphorylates Yes-associated protein (YAP) to regulate apoptosis

Tomlinson, V., Gudmundsdottir, K. K., Luong, P., Leung, K.-Y., Knebel, A., & Basu, S. (2010) · Cell Death and Disease · doi:10.1038/cddis.2010.7 · Cited by 132 · see citing works

Structures of YAP protein domains reveal promising targets for development of new cancer drugs

Sudol, M., Shields, D. C., & Farooq, A. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.05.002 · Cited by 122 · see citing works

Interleukin 1α Sustains the Expression of Inflammatory Factors in Human Pancreatic Cancer Microenvironment by Targeting Cancer-Associated Fibroblasts

Tjomsland, V., Spångéus, A., Välilä, J., Sandström, P., Borch, K., Druid, H., Falkmer, S. E., Falkmer, S., Messmer, D., & Larsson, M. (2011) · Neoplasia · doi:10.1593/neo.11332 · Cited by 122 · see citing works

Targeting Mutant KRAS for Anticancer Therapeutics: A Review of Novel Small Molecule Modulators

Wang, Y., Kaiser, C. E., Frett, B., & Li, H. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3017706 · Cited by 121 · see citing works

The activity of Gli transcription factors is essential for Kras-induced pancreatic tumorigenesis

Rajurkar, M., DeJesus-Monge, W. E., Driscoll, D. R., Appleman, V. A., Huang, H., Cotton, J. L., Klimstra, D., Zhu, L., Simin, K., Xu, L., et al. (2012) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1114168109 · Cited by 119 · see citing works

Loss of the Transcription Factor GLI1 Identifies a Signaling Network in the Tumor Microenvironment Mediating KRAS Oncogene-induced Transformation

Mills, L. D., Zhang, Y., Marler, R. J., Herreros‐Villanueva, M., Zhang, L., Almada, L. L., Couch, F. J., Wetmore, C., di Magliano, M. P., & Fernández-Zapico, M. E. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.438846 · Cited by 119 · see citing works

Regulation of the Hippo pathway and implications for anticancer drug development

Park, H. W., & Guan, K. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.08.006 · Cited by 117 · see citing works

Delayed Progression of Pancreatic Intraepithelial Neoplasia in a Conditional KrasG12D Mouse Model by a Selective Cyclooxygenase-2 Inhibitor

Funahashi, H., Satake, M., Dawson, D. W., Huynh, N.-A., Reber, H. A., Hines, O. J., & Eibl, G. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0970 · Cited by 116 · see citing works

IL-6 stimulates Th2 type cytokine secretion and upregulates VEGF and NRP-1 expression in pancreatic cancer cells

Feurino, L. W., Zhang, Y., Bharadwaj, U., Zhang, R., Li, F., Fisher, W. E., Brunicardi, F. C., Chen, C., Yao, Q. C., & Li, M. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.7.4328 · Cited by 115 · see citing works

Cyr61/CCN1 signaling is critical for epithelial-mesenchymal transition and stemness and promotes pancreatic carcinogenesis

Haque, I., Mehta, S., Majumder, M., Dhar, K., De, A., McGregor, D., Van Veldhuizen, P. J., Banerjee, S. K., & Banerjee, S. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-8 · Cited by 113 · see citing works

YAP1 and VGLL3, encoding two cofactors of TEAD transcription factors, are amplified and overexpressed in a subset of soft tissue sarcomas

Hélias‐Rodzewicz, Z., Pérot, G., Chibon, F., Ferreira, C., Lagarde, P., Terrier, P., Coindre, J., & Aurias, A. (2010) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20825 · Cited by 107 · see citing works

Desmoplastic Reaction Influences Pancreatic Cancer Growth Behavior

Hartel, M., di Mola, F. F., Gardini, A., et al. (2004) · World Journal of Surgery · doi:10.1007/s00268-004-7147-4 · Cited by 107 · see citing works

Pancreatic acinar cells in culture: expression of acinar and ductal antigens in a growth-related manner.

Lisle, R. C. D., & Logsdon, C. D. (1990) · PubMed · Cited by 104 · see citing works

YAP1 is involved in mesothelioma development and negatively regulated by Merlin through phosphorylation

Yokoyama, T., Osada, H., Murakami, H., Tatematsu, Y., Taniguchi, T., Kondo, Y., Yatabe, Y., Hasegawa, Y., Shimokata, K., Horio, Y., et al. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn200 · Cited by 101 · see citing works

Cell Intrinsic Role of COX-2 in Pancreatic Cancer Development

Hill, R., Li, Y., Tran, L. M., Dry, S., Calvopina, J. H., Garcia, A. J., Kim, C. G., Wang, Y., Donahue, T. R., Herschman, H. R., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0342 · Cited by 99 · see citing works

A Novel Acetylation Cycle of Transcription Co-activator Yes-associated Protein That Is Downstream of Hippo Pathway Is Triggered in Response to SN2 Alkylating Agents

Hata, S., Hirayama, J., Kajiho, H., Nakagawa, K., Hata, Y., Katada, T., Furutani‐Seiki, M., & Nishina, H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.334714 · Cited by 95 · see citing works

Down-Regulation of Yes Associated Protein 1 Expression Reduces Cell Proliferation and Clonogenicity of Pancreatic Cancer Cells

Diep, C. H., Zucker, K. M., Hostetter, G. H., Watanabe, A. T., Hu, C., Muñoz, R. M., Hoff, D. D. V., & Han, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032783 · Cited by 87 · see citing works

LKB1 tumor suppressor regulates AMP kinase/mTOR-independent cell growth and proliferation via the phosphorylation of Yap

Nguyen, H. B., Babcock, J. T., Wells, C. D., & Quilliam, L. A. (2013) · Oncogene · doi:10.1038/onc.2012.431 · Cited by 84 · see citing works

Ras Signaling Enhances the Activity of C/EBPα to Induce Granulocytic Differentiation by Phosphorylation of Serine 248

Behre, G., Singh, S. M., Liu, H., Bortolin, L. T., Christopeit, M., Radomska, H. S., Rangatia, J., Hiddemann, W., Friedman, A. D., & Tenen, D. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202301200 · Cited by 81 · see citing works

Progressive Metaplastic and Dysplastic Changes in Mouse Pancreas Induced by Cyclooxygenase-2 Overexpression

Colby, J. K., Klein, R. D., McArthur, M. J., Conti, C. J., Kiguchi, K., Kawamoto, T., Riggs, P. K., Pavone, A., Sawicki, J. A., & Fischer, S. M. (2008) · Neoplasia · doi:10.1593/neo.08330 · Cited by 81 · see citing works

Gemcitabine Plus Celecoxib in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma

Dragovich, T., Burris, H. A., Loehrer, P. J., et al. (2008) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e31815878c9 · Cited by 74 · see citing works

Pancreatic cancer circulating tumour cells express a cell motility gene signature that predicts survival after surgery

Sergeant, G., van Eijsden, R. G. E., Roskams, T., Duppen, V. V., & Topal, B. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-527 · Cited by 68 · see citing works

US National Cancer Institute's new Ras project targets an old foe

Thompson, H. (2013) · Nature Medicine · doi:10.1038/nm0813-949 · Cited by 63 · see citing works

Apricoxib, a Novel Inhibitor of COX-2, Markedly Improves Standard Therapy Response in Molecularly Defined Models of Pancreatic Cancer

Kirane, A., Toombs, J. E., Ostapoff, K. T., Carbon, J. G., Zaknoen, S. L., Braunfeld, J. B., Schwarz, R. E., Burrows, F. J., & Brekken, R. A. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0453 · Cited by 59 · see citing works

The Matricellular Protein CCN1/Cyr61 Is a Critical Regulator of Sonic Hedgehog in Pancreatic Carcinogenesis

Haque, I., De, A., Majumder, M., Mehta, S., McGregor, D. H., Banerjee, S. K., Veldhuizen, P., & Banerjee, S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.389064 · Cited by 55 · see citing works

Preinvasive Duct-Derived Neoplasms in Pancreas of Keratin 5–Promoter Cyclooxygenase-2 Transgenic Mice

Müller‐Decker, K., Fürstenberger, G., Annan, N., Kucher, D., Pohl–Arnold, A., Steinbauer, B., Esposito, I., Chiblak, S., Friess, H., Schirmacher, P., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.053 · Cited by 53 · see citing works

Expression of Yes-associated protein in non-small cell lung cancer and its relationship with clinical pathological factors.

Su, L., Ma, W.-X., Yuan, J.-F., et al. (2012) · PubMed · Cited by 46 · see citing works

Yes-associated protein promotes cell proliferation by activating Fos Related Activator-1 in oral squamous cell carcinoma

Zhang, L., Ye, D., Pan, H., Wei, K., Wang, L., Wang, X.-D., Shen, G.-F., & Zhang, Z. (2011) · Oral Oncology · doi:10.1016/j.oraloncology.2011.06.003 · Cited by 41 · see citing works

Expression and Yes-Associated Protein in Gastric Adenocarcinoma and Inhibitory Effects of its Knockdown on Gastric Cancer Cell Proliferation and Metastasis

Zhang, J., Xu, Z., Yang, Y.-C., et al. (2012) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201202500304 · Cited by 39 · see citing works

Identification of Mechanism That Couples Multisite Phosphorylation of Yes-associated Protein (YAP) with Transcriptional Coactivation and Regulation of Apoptosis

Lee, K.-K., & Yonehara, S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.296954 · Cited by 38 · see citing works

Stage-specific Control of Connective Tissue Growth Factor (CTGF/CCN2) Expression in Chondrocytes by Sox9 and β-Catenin

Huang, B., Brugger, S. M., & Lyons, K. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.108498 · Cited by 37 · see citing works

Requirement of NEMO/IKKγ for effective expansion of KRAS-induced precancerous lesions in the pancreas

Maier, H. J., Wagner, M., Schips, T. G., Salem, H. H., Baumann, B., & Wirth, T. C. (2012) · Oncogene · doi:10.1038/onc.2012.272 · Cited by 34 · see citing works

Leveraging two-way probe-level block design for identifying differential gene expression with high-density oligonucleotide arrays

Barrera, L. O., Benner, C. W., Tao, Y.-C., et al. (2004) · BMC Bioinformatics · doi:10.1186/1471-2105-5-42 · Cited by 28 · see citing works

Disputed Paternity: The Uncertain Ancestry of Pancreatic Ductal Neoplasia

Maitra, A., & Leach, S. D. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.11.015 · Cited by 27 · see citing works

Yes-associated protein (YAP65) in relation to Smad7 expression in human pancreatic ductal adenocarcinoma

Guo, J., Kleeff, J., Zhao, Y., Li, J., Giese, T., Esposito, I., Büchler, M., Korc, M., & Friess, H. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.17.5.761 · Cited by 25 · see citing works

Isolation and Culture of Rhesus Monkey Pancreatic Ductules and Ductule-like Epithelium

Githens, S., Patke, C. L., & Schexnayder, J. A. (1994) · Pancreas · doi:10.1097/00006676-199401000-00003 · Cited by 8 · see citing works

Hippo pathway in organ size control, tissue homeostasis, and cancer

Yu, F.-X., Zhao, B., & Guan, K.-L. (2015) · Cell · doi:10.1016/j.cell.2015.10.044 · Cited by 2,206 · see citing works

YAP/TAZ at the Roots of Cancer

Zanconato, F., Cordenonsi, M., & Piccolo, S. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.05.005 · Cited by 1,970 · see citing works

The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies

Lin, L., Sabnis, A. J., Chan, E., Olivas, V., Cade, L., Pazarentzos, E., Asthana, S., Neel, D., Yan, J. J., Lu, X., et al. (2015) · Nature Genetics · doi:10.1038/ng.3218 · Cited by 551 · see citing works

Genetics and biology of pancreatic ductal adenocarcinoma

Ying, H., Dey, P., Yao, W., Kimmelman, A. C., Draetta, G. F., Maitra, A., & DePinho, R. A. (2016) · Genes &amp; Development · doi:10.1101/gad.275776.115 · Cited by 527 · see citing works

The molecular biology of pancreatic adenocarcinoma: Translational challenges and clinical perspectives

Wang, S., Zheng, Y., Yang, F., Zhu, L., Zhu, X.-Q., Wang, Z.-F., Wu, X.-L., Zhou, C.-H., Yan, J.-Y., Hu, B.-Y., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00659-4 · Cited by 369 · see citing works

YAP Drives Growth by Controlling Transcriptional Pause Release from Dynamic Enhancers

Galli, G. G., Carrara, M., Yuan, W.-C., Valdes-Quezada, C., Gurung, B., Pepe-Mooney, B., Zhang, T., Geeven, G., Gray, N. S., de Laat, W., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.09.001 · Cited by 290 · see citing works

Regulation of TEAD Transcription Factors in Cancer Biology

Huh, H., Kim, D., Jeong, H.-S., & Park, H. (2019) · Cells · doi:10.3390/cells8060600 · Cited by 259 · see citing works

YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma

Kim, M. H., Kim, C. G., Kim, S.-K., Shin, S. J., Choe, E. A., Park, S.-H., Shin, E.-C., & Kim, J. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0320 · Cited by 241 · see citing works

Molecular Pathogenesis of Pancreatic Cancer

Grant, T. J., Hua, K., & Singh, A. (2016) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2016.09.008 · Cited by 237 · see citing works

Insights into recent findings and clinical application of YAP and TAZ in cancer

Franklin, J. M., Wu, Z., & Guan, K.-L. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-023-00579-1 · Cited by 213 · see citing works

The acinar differentiation determinant PTF1A inhibits initiation of pancreatic ductal adenocarcinoma

Krah, N. M., De La O, J.-P., Swift, G. H., Hoang, C. Q., Willet, S. G., Chen Pan, F., Cash, G. M., Bronner, M. P., Wright, C. V., MacDonald, R. J., et al. (2015) · eLife · doi:10.7554/elife.07125 · Cited by 166 · see citing works

Drugging KRAS: Current perspectives and state-of-art review

Parikh, K., Banna, G., Liu, S. V., Friedlaender, A., Desai, A., Subbiah, V., & Addeo, A. (2022) · Journal of Hematology &amp; Oncology · doi:10.1186/s13045-022-01375-4 · Cited by 164 · see citing works

Epithelial and stromal co-evolution and complicity in pancreatic cancer

Hingorani, S. R. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-022-00530-w · Cited by 108 · see citing works

Deregulation of the Hippo pathway in soft-tissue sarcoma promotes FOXM1 expression and tumorigenesis

Eisinger-Mathason, T. S. K., Mucaj, V., Biju, K. M., Nakazawa, M. S., Gohil, M., Cash, T. P., Yoon, S. S., Skuli, N., Park, K. M., Gerecht, S., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1420005112 · Cited by 103 · see citing works

Hippo pathway mediates resistance to cytotoxic drugs

Gujral, T. S., & Kirschner, M. W. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1703096114 · Cited by 91 · see citing works

Synthetic Lethal Vulnerabilities in <i>KRAS</i>-Mutant Cancers

Aguirre, A. J., & Hahn, W. C. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031518 · Cited by 90 · see citing works

GNASR201C Induces Pancreatic Cystic Neoplasms in Mice That Express Activated KRAS by Inhibiting YAP1 Signaling

Ideno, N., Yamaguchi, H., Ghosh, B., Gupta, S., Okumura, T., Steffen, D. J., Fisher, C. G., Wood, L. D., Singhi, A. D., Nakamura, M., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.08.006 · Cited by 80 · see citing works

Rigidity controls human desmoplastic matrix anisotropy to enable pancreatic cancer cell spread via extracellular signal-regulated kinase 2

Malik, R., Luong, T., Cao, X., Han, B., Shah, N., Franco-Barraza, J., Han, L., Shenoy, V. B., Lelkes, P. I., & Cukierman, E. (2019) · Matrix Biology · doi:10.1016/j.matbio.2018.11.001 · Cited by 74 · see citing works

YAP1 oncogene is a context-specific driver for pancreatic ductal adenocarcinoma

Tu, B., Yao, J., Ferri-Borgogno, S., Zhao, J., Chen, S., Wang, Q., Yan, L., Zhou, X., Zhu, C., Bang, S., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.130811 · Cited by 75 · see citing works

Lipophilic statins inhibit YAP nuclear localization, co-activator activity and colony formation in pancreatic cancer cells and prevent the initial stages of pancreatic ductal adenocarcinoma in KrasG12D mice

Hao, F., Xu, Q., Wang, J., Yu, S., Chang, H.-H., Sinnett-Smith, J., Eibl, G., & Rozengurt, E. (2019) · PLOS ONE · doi:10.1371/journal.pone.0216603 · Cited by 55 · see citing works

KRAS Mutation Dictates the Cancer Immune Environment in Pancreatic Ductal Adenocarcinoma and Other Adenocarcinomas

Gu, M., Gao, Y., & Chang, P. (2021) · Cancers · doi:10.3390/cancers13102429 · Cited by 35 · see citing works

Dasatinib sensitises KRAS -mutant cancer cells to mitogen-activated protein kinase kinase inhibitor via inhibition of TAZ activity

Rao, G., Kim, I.-K., Conforti, F., Liu, J., Zhang, Y.-W., & Giaccone, G. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.05.013 · Cited by 34 · see citing works

PDAC as an immune evasive disease: can 3D model systems aid to tackle this clinical problem?

Narayanan, S., Vicent, S., & Ponz-Sarvisé, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.787249 · Cited by 24 · see citing works

Isoprenylcysteine carboxylmethyltransferase is required for the impact of mutant KRAS on TAZ protein level and cancer cell self-renewal

Chai, T. F., Manu, K. A., Casey, P. J., & Wang, M. (2020) · Oncogene · doi:10.1038/s41388-020-1364-7 · Cited by 20 · see citing works

TEAD Inhibitors Sensitize KRASG12C Inhibitors via Dual Cell Cycle Arrest in KRASG12C-Mutant NSCLC

Tammaccaro, S. L., Prigent, P., Le Bail, J.-C., Dos-Santos, O., Dassencourt, L., Eskandar, M., Buzy, A., Venier, O., Guillemot, J.-C., Veeranagouda, Y., et al. (2023) · Pharmaceuticals · doi:10.3390/ph16040553 · Cited by 18 · see citing works

Yorkie-Cactus (IκBα)-JNK axis promotes tumor growth and progression in Drosophila

Snigdha, K., Singh, A., & Kango-Singh, M. (2021) · Oncogene · doi:10.1038/s41388-021-01831-4 · Cited by 11 · see citing works

Therapeutic targeting of syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancers

Theardy, M. S., Takeda, M., Sorokin, A., Chen, S., Yang, Z., Wang, X., Kanikarla, P., Coker, O., Nguyen, P., Wei, Y., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102253 · Cited by 6 · see citing works